Literature DB >> 16235026

p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes.

M Saunders1, M B Eldeen, L Del Valle, K Reiss, F Peruzzi, G Mameli, B B Gelman, K Khalili, S Amini, B E Sawaya.   

Abstract

HIV-1 Tat is a potent transcriptional activator of the viral promoter with the ability to modulate a number of cellular regulatory circuits including apoptosis. Tat exerts its effects through interaction with viral as well as cellular proteins. Here, we studied the influence of p73, a protein that is implicated in apoptosis and cell cycle control, on Tat apoptotic function in the central nervous system. We recently demonstrated the ability of Tat to associate with p73, and that this association modulates Tat transcriptional activity (Amini et al., Mol Cell Biol 2005; 18: 8126-8138). We demonstrated that p73 interferes with Tat-mediated apoptosis by preventing the up-regulation of Bax and down-regulation of Bcl-2 proteins in astrocytes. Thus, the interplay between Tat and p73 may affect Tat contribution to apoptotic events in the brain, limiting its involvement in the neuropathology often observed in the brains of HIV-1 patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235026     DOI: 10.1007/s10495-005-2467-x

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  11 in total

1.  Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice.

Authors:  Elona Rrapo; Yuyan Zhu; Jun Tian; Huayan Hou; Adam Smith; Francisco Fernandez; Jun Tan; Brian Giunta
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

2.  HIV-1 Vpr deregulates calcium secretion in neural cells.

Authors:  Inna Rom; Satish L Deshmane; Ruma Mukerjee; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Brain Res       Date:  2009-03-25       Impact factor: 3.252

3.  Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.

Authors:  Satish L Deshmane; Ruma Mukerjee; Shongshan Fan; Luis Del Valle; Carine Michiels; Thersa Sweet; Inna Rom; Kamel Khalili; Jay Rappaport; Shohreh Amini; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

4.  Involvement of the p53 and p73 transcription factors in neuroAIDS.

Authors:  Ruma Mukerjee; Satish L Deshmane; Shongshan Fan; Luis Del Valle; Martyn K White; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2008-09-17       Impact factor: 4.534

5.  HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity.

Authors:  Giovanni Passiatore; Slava Rom; Davide Eletto; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2008-10-31

6.  Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.

Authors:  Cecilia Sgadari; Giovanni Barillari; Clelia Palladino; Stefania Bellino; Brunella Taddeo; Elena Toschi; Barbara Ensoli
Journal:  Int J Vasc Med       Date:  2011-10-09

Review 7.  Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Authors:  Asen Bagashev; Bassel E Sawaya
Journal:  Virol J       Date:  2013-12-21       Impact factor: 4.099

8.  HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein.

Authors:  Jiyoung Kim; Jee-Hyun Yoon; Yeon-Soo Kim
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

Review 9.  p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?

Authors:  Chao Wang; Cui Rong Teo; Kanaga Sabapathy
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

Review 10.  The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.

Authors:  Sonia Mediouni; Maria Cecilia Garibaldi Marcondes; Courtney Miller; Jay P McLaughlin; Susana T Valente
Journal:  Front Microbiol       Date:  2015-10-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.